[Federal Register Volume 75, Number 160 (Thursday, August 19, 2010)]
[Notices]
[Pages 51273-51275]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-20572]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Expanded Human Immunodeficiency Virus (HIV) Testing for
Disproportionately Affected Populations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
Notice of Intent to increase funding available to make awards under
the Centers for Disease Control and Prevention Funding Opportunity
Announcement CDC-RFA-PS10-10138, ``Expanded Human Immunodeficiency
Virus (HIV) Testing for Disproportionately Affected Populations''.
Additional funding from the Patient Protection and Affordable Care Act
has been allocated for awards to state and county and local public
health departments with at least 175 estimated combined AIDS diagnoses
among Blacks/African Americans and Hispanics/Latinos in 2007.
SUMMARY: This notice provides public notice of CDC's intent to increase
available funding for the Centers for Disease Control and Prevention
Funding Opportunity Announcement PS10-10138, ``Expanded Human
Immunodeficiency Virus (HIV) Testing for Disproportionately Affected
Populations'' to make awards to state and county and local public
health departments. It is the intent of CDC to increase the amount of
funds available to applicants who applied for awards under the
previously announced funding opportunity CDC-RFA-PS10-10138, which
closed on June 24, 2010.
CDC received additional funding through the Patient Protection
Affordable Care Act (PPACA), Section 4002 Prevention and Public Health
Fund. Accordingly CDC adds the following information to the previously
published funding opportunity announcement:
--Catalog of Federal Domestic Assistance Number: 93.523 The Affordable
Care Act: Human Immunodeficiency Virus (HIV) Prevention and Public
Health Fund Activities.
--Authority: This program is authorized under Sections 301 and 318 of
the Public Health Service Act (42 U.S.C. Section 241 and 247c), as
amended, and Section 4002 of the Patient
[[Page 51274]]
Protection and Affordable Care Act (Pub. L. 111-148).
--Reporting Requirements: Recipients of the PPACA funds through this
funding opportunity announcement are required to comply with the
reporting requirements, terms and conditions set forth in the published
version of the PS10-10138, ``Expanded Human Immunodeficiency Virus
(HIV) Testing for Disproportionately Affected Populations'' (CDC-RFA-
PS10-10138).
--CFDA Number 93.523 The Affordable Care Act: Human Immunodeficiency
Virus (HIV) Prevention and Public Health Fund Activities is the PPACA-
specific CFDA number for this initiative. It is included in addition to
the CFDA Number 93.940, HIV Prevention Activities for Health
Departments, published in the above-referenced Funding Opportunity
Announcement (FOA).
Award Information:
Type of Award: Cooperative Agreement.
Fiscal Year Funds: Fiscal Year 2010, Funding for this announcement
will include a combination of HIV Prevention funding and funds from the
PPACA, Prevention and Public Health Fund. Available funding amounts,
including the additional PPHF funds, are as follows.
Part A--HIV Screening and HIV Counseling, Testing, and Referral
Approximate Current Fiscal Year Funding: Up to $60,000,000 total
(to include up to $55,633,000 in Enhanced HIV Testing funds and adding
$4,367,000 in Patient Protection and Affordable Care Act of 2010
funds).
Approximate Total Project Period Funding: $166,899,000. (This
amount is an estimate, and is subject to availability of funds. This
amount includes direct and indirect costs.)
Approximate Number of Awards: 30.
Approximate Average Award: $2,000,000. The average awards will be
proportionately based on estimated combined 2007 Black/African American
and Hispanic/Latino AIDS diagnoses for eligible jurisdictions. (These
amounts are for the first 12-month budget period, and include both
direct and indirect costs.)
Floor and Ceiling of Individual Award Ranges:
------------------------------------------------------------------------
Floor of REVISED Ceiling
Jurisdiction individual award of individual
range award range*
------------------------------------------------------------------------
Florida............................. $4,307,446 $6,818,721
New York City....................... 3,998,517 6,329,161
California.......................... 2,482,306 3,926,423
Texas............................... 2,094,529 3,311,912
New York State...................... 1,861,862 2,943,206
Georgia............................. 1,788,184 2,826,449
Maryland............................ 1,700,288 2,687,160
North Carolina...................... 1,303,462 2,058,310
Louisiana........................... 1,302,170 2,056,262
Puerto Rico......................... 1,258,222 1,986,618
Houston............................. 1,197,470 1,890,344
District of Columbia................ 1,140,596 1,800,216
New Jersey.......................... 1,059,163 1,671,169
Philadelphia........................ 1,042,359 1,644,540
South Carolina...................... 985,485 1,554,411
Chicago............................. 968,681 1,527,782
Virginia............................ 852,348 1,343,429
Los Angeles......................... 803,229 1,265,591
Pennsylvania........................ 801,937 1,263,543
Michigan............................ 798,059 1,257,398
Tennessee........................... 774,792 1,220,527
Illinois............................ 707,578 1,114,012
Ohio................................ 684,311 1,077,141
Massachusetts....................... 667,507 1,050,512
Alabama............................. 642,948 1,011,593
Mississippi......................... 605,463 952,191
Connecticut......................... 602,878 948,093
Missouri............................ 549,881 864,111
Arizona............................. 542,126 851,820
San Francisco....................... 476,204 747,353
------------------------------------------------------------------------
* These ceilings are for the first 12-month budget period and include
direct and indirect costs.
Part B--Enhanced Linkage to Medical Care and Partner Services
Approximate Current Fiscal Year Funding: $4,000,000.
Approximate Total Project Period Funding: $12,000,000 (This amount
is an estimate, and is subject to availability of funds. This amount
includes direct and indirect costs.)
Approximate Number of Awards: Up to 20.
Approximate Average Award: $200,000 (This amount is for the first
12-month budget period, and includes both direct and indirect costs.)
Floor of Individual Award Range: $ 150,000.
Ceiling of Individual Award Range: $ 225,000 (This ceiling is for
the first 12-month budget period and includes direct and indirect
costs.)
Both Part A (HIV Screening and HIV Counseling, Testing, and Referral)
and Part B (Enhanced Linkage to Medical Care and Partner Services)
Anticipated Award Date: September 30, 2010.
Budget Period Length: 12 months.
Project Period Length: 3 years (Availability of PPACA funds beyond
the initial 12 months will be based on availability of future funding.)
[[Page 51275]]
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal government.
Application Selection Process
CDC will apply the same selection methodology published in the CDC-
RFA-PS10-10138.
Funding Authority
CDC will add the PPACA Authority to that which is currently
reflected in the published Funding Opportunity CDC-RFA-PS10-10138. The
revised funding authority language will read:
--This program is authorized under Sections 301 and 318 of the Public
Health Service Act (42 U.S.C. Section 241 and 247c), as amended, and
Section 4002 of the Patient Protection and Affordable Care Act (Pub. L.
111-148).
DATES: The effective date for this action is August 19, 2010 and
remains in effect until the expiration of the project period of the
PPACA funded applications.
FOR FURTHER INFORMATION CONTACT: Elmira Benson, Acting Deputy Director,
Centers for Disease Control and Prevention, 2920 Brandywine Road,
Atlanta, GA 30341, telephone (770) 488-2802, e-mail:
[email protected].
SUPPLEMENTARY INFORMATION: On March 23, 2010, the President signed into
law the Patient Protection and Affordable Care Act (PPACA), Public Law
111-148. PPACA is designed to improve and expand the scope of health
care coverage for Americans. Cost savings through disease prevention is
an important element of this legislation and PPACA has established a
Prevention and Public Health Fund (PPHF) for this purpose.
Specifically, the legislation states in Section 4002 that the PPHF is
to ``provide for expanded and sustained national investment in
prevention and public health programs to improve health and help
restrain the rate of growth in private and public sector health care
costs.'' PPACA and the Prevention and Public Health Fund make improving
public health a priority with investments to improve public health.
The PPHF states that the Secretary shall transfer amounts in the
Fund to accounts within the Department of Health and Human Services to
increase funding, over the fiscal year 2008 level, for programs
authorized by the Public Health Service Act, for prevention, wellness
and public health activities including prevention research and health
screenings, such as the Community Transformation Grant Program, the
Education and Outreach Campaign for Preventative Benefits, and
Immunization Programs.
PPACA legislation affords an important opportunity to advance
public health across the lifespan and to reduce health disparities by
supporting an intensive community approach to chronic disease
prevention and control.
Therefore, increasing funding available to applicants under this
FOA using the PPHF to further HIV prevention programs is consistent
with the purpose of the PPHF, as stated above, to provide for an
expanded and sustained national investment in prevention and public
health programs. Further, the Secretary allocated funds to CDC,
pursuant to the PPHF, for the types of activities this FOA is designed
to carry out.
Dated: August 13, 2010.
Tanja Popovic, MD, PhD, F(AMM), AM(AAFS),
Deputy Associate Director for Science, Centers for Disease Control and
Prevention.
[FR Doc. 2010-20572 Filed 8-18-10; 8:45 am]
BILLING CODE P